Home
Live Updates
Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030 : comparemela.com
Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
Press ReleaseNicox European Patent Seals ZERVIATE Major Market Coverage to 2030 Patent coverage for ZERVIATE (cetirizine ophthalmic solution), 0.24% in Europe until 2030 January 5, 2022 - release
Related Keywords
Mexico ,
Japan ,
Valbonne ,
Provence Alpes Côd Azur ,
France ,
Paris ,
France General ,
United Kingdom ,
China ,
Canada ,
South Korea ,
Turkey ,
Chinese ,
Gavin Spencer ,
Enregistrement Universel ,
Pharma Bio ,
Kepler Cheuvreux Damien Choplain ,
States Europe ,
Sophia Antipolis ,
Sophie Baumont ,
Santen Pharmaceutical Co Ltd Of Japan ,
Head Of Corporate Development ,
European Patent Office ,
Lifesci Advisors ,
Eyevance Pharmaceuticals ,
Edison Investment Research Pooya Hemami London ,
Garnier Co Dylan Van Haaften Paris ,
Market Coverage ,
Euronext Paris ,
Eastern Europe ,
European Patent ,
Chief Business Officer ,
Drug Application ,
Ocumension Therapeutics ,
Southeast Asian ,
Samil Pharmaceutical ,
Laboratorios Grin ,
South East Asian ,
Mid Caps ,
Investment Research ,
Pooya Hemami ,
New York ,
Damien Choplain ,
Vice President ,
Chief Business ,
Corporate Development ,
Sci Advisors ,
French Autorit ,
Des March ,
Nicox ,
European ,
Patent ,
Deals ,
Erviate ,
Major ,
Market ,
Coverage ,
030 ,
comparemela.com © 2020. All Rights Reserved.